Garattini Silvio Horoscope

G S

Garattini Silvio

Nov 12, 1928

Rating : AA (Data from a birth certificate)

Scorpio
Moon Sign

Libra
Sun Sign

Gemini
Lagan

Biography

Italian pharmacologist who founded the Mario Negri Institute for Pharmacological Research in 1961 of which he became the first director. Over the years, the staff at the institute grew to include approximately 850 researchers at four different locations: Milan, Bergamo, Ranica and Santa Maria Imbaro. From 1965 to 1968 he chaired the European Organisation for Research and Treatment of Cancer (EORTC). He is a member of the "Group 2003", a group of Italian researchers held in high esteem in the global pharmaceutical industry. Garattini is the author of hundreds of publications in international journals and author of several treatises on pharmacology. Link to Wikipedia biography Read less

Latest Info with AI

Update at: Jul 14, 2025

`` Silvio Garattini

Silvio Garattini

Born: November 12, 1928, in Bergamo, Italy

Silvio Garattini is a prominent Italian pharmacologist, physician, and researcher, renowned for his contributions to pharmacology and cancer research. He is the founder and director of the Mario Negri Institute for Pharmacological Research, a prestigious biomedical research organization based in Milan, Italy. The institute, established in 1961, is recognized internationally for its work in various areas, including chemotherapy, neuroscience, and cardiovascular research.

Throughout his career, Garattini has focused on developing new cancer therapies and studying the mechanisms of drug resistance. He has published extensively in scientific journals and received numerous awards and honors for his contributions to science. He has also been a vocal advocate for evidence-based medicine and rational drug use, often speaking out against the overuse of antibiotics and the promotion of unproven treatments. He has been critical of the pharmaceutical industry and has emphasized the importance of independent research in assessing drug efficacy and safety.

Information regarding Garattini's specific ongoing projects, social media presence, and recent news is limited in publicly accessible sources. As a prominent figure in the scientific community, his work is primarily disseminated through scientific publications and conferences. While he may have a presence on platforms like LinkedIn or institutional websites, direct links to personal social media profiles are not readily available.

For the most up-to-date information on his current projects, it's recommended to consult the Mario Negri Institute website or search for recent publications in scientific databases like PubMed.

Key aspects of his contributions:

Founder and Director of the Mario Negri Institute for Pharmacological Research.
Extensive research in cancer therapies and drug resistance.
Advocate for evidence-based medicine and rational drug use.
Critic of pharmaceutical industry practices.
Prolific author of scientific publications.

Disclaimer: Due to the limited public information available, this summary may not reflect the entirety of Silvio Garattini's current activities. The most reliable source for recent updates would be the Mario Negri Institute itself.

```